背景风湿病对孕妇构成风险,导致早产等并发症,先天性心脏传导阻滞,怀孕的损失。预计这些疾病在怀孕期间和产后期间会进一步恶化。这些疾病对妊娠的影响将进一步增加患者的负担,胎儿,内科医生,和医疗保健系统。诊断和治疗的进步改善了结果,使其与健康女性相似,但在多学科诊所密切随访是必不可少的.这项研究的目的是研究患有风湿病的妇女的妊娠结局以及该疾病在怀孕期间的行为。方法在利雅得的阿卜杜勒阿齐兹国王医疗城(KAMC)进行了一项回顾性队列研究,沙特阿拉伯,比较三种风湿病的妊娠结局:干燥综合征(SS),系统性红斑狼疮(SLE),和类风湿关节炎(RA)从2016年到2021年。这项研究包括107名患有风湿病的妇女中的128例怀孕。通过评估孕产妇健康状况来调查妊娠措施和结局,胎儿健康,妊娠并发症,特别是母亲的疾病活动,控制疾病的药物,感染,早产,出生体重,流产/死产,交货方式,出血,先兆子痫,先天性心脏传导阻滞,和新生儿狼疮。结果RA患者55例(妊娠63例),44例SLE(54例SLE怀孕),8例原发性SS(11例SS怀孕)。在大多数怀孕中(n=108;95.58%),患者在妊娠前处于临床缓解期。狼疮性肾炎,在怀孕前缓解,在54例SLE妊娠中有9例(16.67%)被报告。阴道分娩是最常见的分娩方式(n=87;67.97%)。另一方面,剖宫产38例(29.69%)。10例妊娠发生风湿病发作(7.87%)。分娩了122例活产。早产儿出生在25次怀孕(20.16%),16例(13.22%)新生儿需要新生儿重症监护病房(NICU)护理。有趣的是,在41名抗SS相关抗原A(抗SSA)阳性母亲中,有5名(12.2%)新生儿发现先天性心脏传导阻滞(CHB);这五个人中有一个死于心脏传导阻滞。11例新生儿血清学阳性,5人被诊断为新生儿狼疮。结论风湿病患者妊娠结局良好。多学科团队方法和密切的临床随访是这种成功的基石。小剂量泼尼松龙(5mg或更少)是安全的,不会对母体或胎儿健康产生负面影响。CHB是抗SSA阳性孕妇的关注点。
Background Rheumatic diseases pose risks to pregnant women, leading to complications like preterm birth, congenital heart block, and pregnancy loss. These diseases are expected to deteriorate during pregnancy and further in the postpartum period. The impact of these diseases on the pregnancy will add further burden on the patient, fetus, physician, and healthcare system. Advances in diagnosis and treatment have improved outcomes making them similar to that of healthy women, but close follow-up in a multidisciplinary clinic is essential. The objective of this
study is to
study the outcome of pregnancy in women with rheumatological disease and the behavior of the disease during pregnancy. Methods A retrospective cohort
study was conducted in King Abdulaziz Medical City (KAMC) in Riyadh, Saudi Arabia, to compare the outcomes of pregnancy across three rheumatological diseases: Sjogren syndrome (SS), systemic lupus erythematosus (SLE), and rheumatoid arthritis (RA) from 2016 to 2021. A total of 128 pregnancies in 107 women with rheumatological diseases were included in this
study. Pregnancy measures and outcomes were investigated by assessing maternal health, fetal health, and pregnancy complications, specifically maternal disease activity, medications to control the disease, infection, preterm birth, birth weight, abortions/stillbirths, mode of delivery, bleeding, preeclampsia, congenital heart block, and neonatal lupus. Results There were 55 patients with RA (63 RA pregnancies), 44 with SLE (54 SLE pregnancies), and eight with primary SS (11 SS pregnancies). In most of the pregnancies (n= 108; 95.58%), the patients were in clinical remission before pregnancy. Lupus nephritis, which was in remission before pregnancy, has been reported in nine (16.67%) out of 54 SLE pregnancies. Vaginal delivery was the most common mode of delivery (n=87; 67.97%). On the other hand, there were 38 cesarean sections (29.69%). Rheumatological disease flares occurred in 10 pregnancies (7.87%). One hundred and twenty-two live births were delivered. Preterm infants were born in 25 pregnancies (20.16%), and 16 (13.22%) of the newborns needed neonatal intensive care unit (NICU) care. Interestingly, congenital heart block (CHB) was found in five (12.2%) neonates out of 41 anti-SS-related antigen A (anti-SSA) positive mothers; one of those five died from heart block. Eleven neonates were delivered with positive serology, and five were diagnosed with neonatal lupus. Conclusion The outcome of pregnancy in patients with rheumatological disease is favorable. A multidisciplinary team approach and close clinical follow-up are the cornerstone for such success. A small dose of prednisolone (5 mg or less) is safe and will not have a negative impact on maternal or fetal health. CHB is a concern for pregnant women with positive anti-SSA.